乌龙制药20250311
2025-04-15 14:30
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the EuroGen Pharma fourth quarter and full year 2024 earnings call. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Vincent Perrone, head of investor relations. Please go ahead. Thank you, operator. Good morning, everyone. and welcome to Eurogen Pharma's fourth quarter and full year 2024 financial results and business update conference call. Earlier t ...